Text Message Safety Behavior Fading for Social Anxiety

February 20, 2025 updated by: Jesse Cougle, Florida State University

Text Message Safety Behavior Fading Intervention for Social Anxiety

The current study aims to explore the efficacy of a text message based Safety Behavior Fading Intervention compared to an active control intervention.

Study Overview

Detailed Description

Safety behavior fading may be a viable standalone intervention for social anxiety. In the present trial, participants high in social anxiety will be randomized to either receive a daily checklist exercise aimed at eliminating (1) safety behaviors or (2) unhealthy behaviors. Individuals randomly assigned to the safety behavior fading condition will receive instructions to decrease or eliminate their four most habitual social anxiety safety behaviors. In addition, they will receive daily reminders via text message to decrease these behaviors, along with a safety behavior monitoring checklist in which the participant indicates the extent to which they decreased and/or eliminated each safety behavior over the previous day. Individuals randomly assigned to the control condition will receive similar text messages and a daily checklist to encourage fading of unhealthy behaviors. Participants in both conditions will complete checklists for 28 days. After day 14 of treatment, participants will re-select their target safety behaviors or unhealthy behaviors, and will then be prompted to reduce these new behaviors for another 14 days.

Study Type

Interventional

Enrollment (Actual)

201

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Tallahassee, Florida, United States, 32312
        • Florida State University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Social Phobia Inventory Score >29
  • Stable Psychotropic Medications for 4 weeks prior to participation

Exclusion Criteria:

  • Currently participating in psychotherapy for social anxiety

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental: Safety Behavior Fading
This treatment lasts a total of 28 days. Participants will be asked to identify common safety behaviors related to social anxiety. For the next 14 days, participants will receive instructions to fade out these behaviors. After 14 days, participants will be asked to re-select their target safety behaviors and continue to reduce them over the next two weeks.
Participants are asked to reduce or eliminate safety behaviors via text message reminders and checklists to monitor progress.
Active Comparator: Unhealthy Behavior Fading
This treatment lasts a total of 28 days. Participants will be asked to identify common unhealthy behaviors related to social anxiety. For the next 14 days, participants will receive instructions to fade out these behaviors. After 14 days, participants will be asked to re-select their target unhealthy behaviors and continue to reduce them over the next two weeks.
Participants are asked to reduce or eliminate unhealthy behaviors via text message reminders and checklists to monitor progress.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Social Phobia Inventory (SPIN)
Time Frame: Time Frame: Day 0, Day 14, Day 28, Day 56
Self-report scale that measures Social anxiety symptoms. Scores range from 0 to 68 with higher scores indicating higher levels of social anxiety symptoms.
Time Frame: Day 0, Day 14, Day 28, Day 56

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Center For Epidemiological Studies Depression Scale, Ten Item Version (CESD-10)
Time Frame: Time Frame: Day 0, Day 28, Day 56
A 10-item self-report scale measuring depression symptoms; higher scores indicate greater depressive symptoms.
Time Frame: Day 0, Day 28, Day 56
Change in UCLA Loneliness Scale, Short Form (ULS-8)
Time Frame: Time Frame: Day 0, Day 28, Day 56
An 8-item self-report measure of subjective loneliness, with higher scores indicating greater loneliness.
Time Frame: Day 0, Day 28, Day 56
Change in Self-Beliefs Related to Social Anxiety Scale (SBSA)
Time Frame: Time Frame: Day 0, Day 28, Day 56
A 15-item scale measuring common and generally maladaptive beliefs related to social anxiety.
Time Frame: Day 0, Day 28, Day 56
Change in Subtle Avoidance Frequency Examination (SAFE) scale
Time Frame: Time Frame: Day 0, Day 28, Day 56
A 32-item self-report measure of safety behavior usage frequency
Time Frame: Day 0, Day 28, Day 56

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2024

Primary Completion (Actual)

September 1, 2024

Study Completion (Actual)

September 1, 2024

Study Registration Dates

First Submitted

December 5, 2023

First Submitted That Met QC Criteria

December 5, 2023

First Posted (Actual)

December 13, 2023

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 20, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • STUDY2247MOD4140

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Social Anxiety

Clinical Trials on Unhealthy Behavior Fading

Subscribe